Avricore Health (AVCRF) Gains from Investment Securities (2009 - 2020)

Avricore Health has disclosed Gains from Investment Securities across 7 years of filings, most recently posting -$13.2 million for Q4 2022.

• In Q4 2022, Gains from Investment Securities fell 168.65% year-over-year to -$13.2 million; the TTM figure through Dec 2022 stood at -$27.5 million (down 391.26% YoY), while the FY2024 annual figure was -$7304.0, changed N/A from the prior year.
• Gains from Investment Securities slipped to -$13.2 million in Q4 2022, from $11.8 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for AVCRF reached as high as $11.8 million in Q3 2022 and fell as low as -$13.4 million in Q2 2022.
• The 4-year median for Gains from Investment Securities is -$692327.7 (2021), against an average of -$3.7 million.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities plunged 98225.0% — and 2022, when it jumped 1802.36%.
• A 4-year view of Gains from Investment Securities shows it stood at $131194.7 in 2018, then slumped by 103.8% to -$4984.3 in 2020, then slumped by 98225.0% to -$4.9 million in 2021, then tumbled by 168.65% to -$13.2 million in 2022.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$13.2 million, $11.8 million, and -$13.4 million for Q4 2022, Q3 2022, and Q2 2022 respectively.